203 related articles for article (PubMed ID: 23725738)
1. Cone dystrophy with supernormal rod response: novel KCNV2 mutations in an underdiagnosed phenotype.
Zelinger L; Wissinger B; Eli D; Kohl S; Sharon D; Banin E
Ophthalmology; 2013 Nov; 120(11):2338-43. PubMed ID: 23725738
[TBL] [Abstract][Full Text] [Related]
2. Cone dystrophy with supernormal rod response is strictly associated with mutations in KCNV2.
Wissinger B; Dangel S; Jägle H; Hansen L; Baumann B; Rudolph G; Wolf C; Bonin M; Koeppen K; Ladewig T; Kohl S; Zrenner E; Rosenberg T
Invest Ophthalmol Vis Sci; 2008 Feb; 49(2):751-7. PubMed ID: 18235024
[TBL] [Abstract][Full Text] [Related]
3. A novel KCNV2 mutation in a patient taking hydroxychloroquine associated with cone dystrophy with supernormal rod response.
Liu PK; Ryu J; Yeh LK; Chen KJ; Tsang SH; Liu L; Wang NK
Ophthalmic Genet; 2021 Aug; 42(4):458-463. PubMed ID: 33960280
[TBL] [Abstract][Full Text] [Related]
4. Novel KCNV2 mutations in cone dystrophy with supernormal rod electroretinogram.
Ben Salah S; Kamei S; Sénéćhal A; Lopez S; Bazalgette C; Bazalgette C; Eliaou CM; Zanlonghi X; Hamel CP
Am J Ophthalmol; 2008 Jun; 145(6):1099-106. PubMed ID: 18400204
[TBL] [Abstract][Full Text] [Related]
5. Large deletions of the KCNV2 gene are common in patients with cone dystrophy with supernormal rod response.
Wissinger B; Schaich S; Baumann B; Bonin M; Jägle H; Friedburg C; Varsányi B; Hoyng CB; Dollfus H; Heckenlively JR; Rosenberg T; Rudolph G; Kellner U; Salati R; Plomp A; De Baere E; Andrassi-Darida M; Sauer A; Wolf C; Zobor D; Bernd A; Leroy BP; Enyedi P; Cremers FP; Lorenz B; Zrenner E; Kohl S
Hum Mutat; 2011 Dec; 32(12):1398-406. PubMed ID: 21882291
[TBL] [Abstract][Full Text] [Related]
6. Coexistence of KCNV2 associated cone dystrophy with supernormal rod electroretinogram and MFRP related oculopathy in a Turkish family.
Ritter M; Vodopiutz J; Lechner S; Moser E; Schmidt-Erfurth UM; Janecke AR
Br J Ophthalmol; 2013 Feb; 97(2):169-73. PubMed ID: 23143909
[TBL] [Abstract][Full Text] [Related]
7. Analysis of retinal structure and function in cone dystrophy with supernormal rod response.
Abdelkader E; Yasir ZH; Khan AM; Raddadi O; Khandekar R; Alateeq N; Nowilaty S; AlShahrani N; Schatz P
Doc Ophthalmol; 2020 Aug; 141(1):23-32. PubMed ID: 31960170
[TBL] [Abstract][Full Text] [Related]
8. Novel biallelic loss-of-function KCNV2 variants in cone dystrophy with supernormal rod responses.
Kutsuma T; Katagiri S; Hayashi T; Yoshitake K; Iejima D; Gekka T; Kohzaki K; Mizobuchi K; Baba Y; Terauchi R; Matsuura T; Ueno S; Iwata T; Nakano T
Doc Ophthalmol; 2019 Jun; 138(3):229-239. PubMed ID: 30877594
[TBL] [Abstract][Full Text] [Related]
9. Identification of mutations causing inherited retinal degenerations in the israeli and palestinian populations using homozygosity mapping.
Beryozkin A; Zelinger L; Bandah-Rozenfeld D; Shevach E; Harel A; Storm T; Sagi M; Eli D; Merin S; Banin E; Sharon D
Invest Ophthalmol Vis Sci; 2014 Feb; 55(2):1149-60. PubMed ID: 24474277
[TBL] [Abstract][Full Text] [Related]
10. Compound heterozygous KCNV2 variants contribute to cone dystrophy with supernormal rod responses in a Chinese family.
Liu M; Zhu Y; Huang L; Jiang W; Wu N; Song Y; Lu Y; Ma Y
Mol Genet Genomic Med; 2021 Oct; 9(10):e1795. PubMed ID: 34535971
[TBL] [Abstract][Full Text] [Related]
11. Genetics and Disease Expression in the CNGA3 Form of Achromatopsia: Steps on the Path to Gene Therapy.
Zelinger L; Cideciyan AV; Kohl S; Schwartz SB; Rosenmann A; Eli D; Sumaroka A; Roman AJ; Luo X; Brown C; Rosin B; Blumenfeld A; Wissinger B; Jacobson SG; Banin E; Sharon D
Ophthalmology; 2015 May; 122(5):997-1007. PubMed ID: 25616768
[TBL] [Abstract][Full Text] [Related]
12. Maternal uniparental isodisomy of chromosome 6 reveals a TULP1 mutation as a novel cause of cone dysfunction.
Roosing S; van den Born LI; Hoyng CB; Thiadens AA; de Baere E; Collin RW; Koenekoop RK; Leroy BP; van Moll-Ramirez N; Venselaar H; Riemslag FC; Cremers FP; Klaver CC; den Hollander AI
Ophthalmology; 2013 Jun; 120(6):1239-46. PubMed ID: 23499059
[TBL] [Abstract][Full Text] [Related]
13. Novel mutations in the KCNV2 gene in patients with cone dystrophy and a supernormal rod electroretinogram.
Thiagalingam S; McGee TL; Weleber RG; Sandberg MA; Trzupek KM; Berson EL; Dryja TP
Ophthalmic Genet; 2007 Sep; 28(3):135-42. PubMed ID: 17896311
[TBL] [Abstract][Full Text] [Related]
14. Clinical course of two siblings with potassium voltage-gated channel modifier subfamily V member 2 (KCNV2)-associated retinopathy.
Sato T; Kuniyoshi K; Hayashi T; Nishiwaki H; Mizobuchi K; Kusaka S
Doc Ophthalmol; 2024 Jun; 148(3):173-182. PubMed ID: 38630375
[TBL] [Abstract][Full Text] [Related]
15. Molecular characteristics of four Japanese cases with KCNV2 retinopathy: report of novel disease-causing variants.
Fujinami K; Tsunoda K; Nakamura N; Kato Y; Noda T; Shinoda K; Tomita K; Hatase T; Usui T; Akahori M; Itabashi T; Iwata T; Ozawa Y; Tsubota K; Miyake Y
Mol Vis; 2013; 19():1580-90. PubMed ID: 23885164
[TBL] [Abstract][Full Text] [Related]
16. Cone dystrophy with supernormal rod responses: A rare KCNV2 gene variant.
Esteves-Leandro J; Torres-Costa S; Estrela-Silva S; Santos-Silva R; Brandão E; Grangeia A; Fernandes S; Oliveira R; Falcão-Reis F; Rocha-Sousa A
Eur J Ophthalmol; 2022 Jan; 32(1):664-672. PubMed ID: 33706576
[TBL] [Abstract][Full Text] [Related]
17. Mutations in the gene KCNV2 encoding a voltage-gated potassium channel subunit cause "cone dystrophy with supernormal rod electroretinogram" in humans.
Wu H; Cowing JA; Michaelides M; Wilkie SE; Jeffery G; Jenkins SA; Mester V; Bird AC; Robson AG; Holder GE; Moore AT; Hunt DM; Webster AR
Am J Hum Genet; 2006 Sep; 79(3):574-9. PubMed ID: 16909397
[TBL] [Abstract][Full Text] [Related]
18. RETINA-specific expression of Kcnv2 is controlled by cone-rod homeobox (Crx) and neural retina leucine zipper (Nrl).
Aslanidis A; Karlstetter M; Walczak Y; Jägle H; Langmann T
Adv Exp Med Biol; 2014; 801():31-41. PubMed ID: 24664678
[TBL] [Abstract][Full Text] [Related]
19. Variable retinal phenotypes caused by mutations in the X-linked photopigment gene array.
Mizrahi-Meissonnier L; Merin S; Banin E; Sharon D
Invest Ophthalmol Vis Sci; 2010 Aug; 51(8):3884-92. PubMed ID: 20220053
[TBL] [Abstract][Full Text] [Related]
20. The spectrum of retinal diseases caused by NR2E3 mutations in Israeli and Palestinian patients.
Bandah D; Merin S; Ashhab M; Banin E; Sharon D
Arch Ophthalmol; 2009 Mar; 127(3):297-302. PubMed ID: 19273793
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
